Purpose: To evaluate the visual outcome after laser photocoagulation in diabetic retinopathy.
INTRODUCTION
Diabetic retinopathy is progressive dysfunction of retinal vessels caused by chronic hyperglycemia 1 . It is a microangiopathy which primarily affects the precapillary arterioles, capillaries and post capillary venules although larger vessels may also be involved. 
Risk Factors for Diabetic Retinopathy

Diabetic Maculopathy
Changes in macular region need special mention, due to their effect on vision. These changes may be associated with non-proliferative diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR). It is termed as Clinically Significant Macular Edema (CSME) 3, 4 . If one of the following three criteria"s are present.
Thickening of retina at or within 500 micron of the centre of the fovea.
Hard exudates at or within 500 micron of the centre of the fovea associated with adjacent retinal thickening.
Development of a zone of retinal thickening one disc diameter or larger in size, at least a part of which is within one disc diameter of the foveal centre.
Clinico-angiographically diabetic retinopathy can be classified as 5, 6 :
Focal exudative maculopathy
Diffuse exudative maculopathy
Ischaemic maculopathy
Mixed maculopathy
Management
1.
Screening:
To prevent visual loss occurring from diabetic retinopathy a periodic follow up is very important for a timely intervention. 7, 8 Control of systemic risk factors like strict metabolic control of blood sugar, lipid reduction.
Medical Treatment
Role of pharmacological modulations include protein kinase C (PKC)
inhibitor, VEGF inhibitors, aldolase reductase and ace inhibitors.
Role of intravitreal steroids like intra-vitreal triamcinolone acetonide (2-4mg) in reducing macular edema.
Laser Photocoagulation
Laser light is monochromatic, unidirectional, coherent and collimated.
Laser Photocoagulation for Diabetic Macular Edema 4, 9 Focal Laser: for all focal leaks located between 500 -3000 from the centre of macula.
Grid Laser: All areas of thickened retina within the arcade are treated with 100 to 200 spot size placed one burn width apart at 0.1 second duration.
Treatment within papillomacular bundle is usually avoided.
Pan-retinal photocoagulation -PRP
Indications
PDR with HRCs
Neovascularization
Severe NPDR
Laser Parameters 10
Spot size -200-500 m Duration -0.1 sec
Intensitymedium
Placementone burn, apart at the entire capillary non-perfusion area.
Sequence of PRP Steps 10
Step -1: Inferior retina below the inferior temporal arcade.
Step -2: Protective barrier around the macula to prevent inadvertent treatment of the fovea above the superotemporal arcade.
Step -3: Nasal to the disc completion of the posterior pole treatment.
Step -4: Peripheral treatment until completion. 11, 12, 13 These include accidental foveal burns, macular edema and macular pucker, 
Complication of Laser Photocoagulation
Surgical Treatment of Diabetic Retinopathy
Pars plana vitrectomy for treating severe complications of PDR like severe persistent vitreous haemorrhage, progressive tractional retinal detachment, combined tractional and rhegmatogenous retinal detachment, pre-macular subhyaloid hemorrhage.
MATERIALS AND METHODS
This hospital based study was conducted in the Postgraduate Department of 
a -comparison between baseline and first visit visual acuity b -comparison between baseline and final visit visual acuity c -comparison between first visit and final visit visual acuity d -overall comparison
We observed that after comparing baseline visual acuity with BCVA at 1 st visit, there was a statistically significant improvement seen (p=0.000). There was significant improvement between baseline visual acuity and BCVA at final visit (3 months) (p=0.000). Overall comparison shows significant improvement (p=0.000). We observed that 62 (62%) patients showed improvement by 1 or more lines on Snell`s chart, 26 (26%) remains unchanged and 12 (12%) deteriorated from baseline visual acuity. The overall mean improvement was 0.56 lines on
Snell`s chart that is clinically significant. 
DISCUSSION
With changing life style and more urbanization, diseases like diabetes and hypertension have become more common, leading to a greater prevalence of diabetes and hypertensive retinopathy. 19, 20, 21 found a statistically significant relations between the two. The variation in my study may be due to shorter follow up time and different clinical profile of the patients.
CONCLUSION
The results of presented collection of hundred patients shows a favourable influence of photocoagulation on the improvement and preservation of baseline visual acuity.
Timely focal and grid laser photocoagulation helps in improving and stabilizing the visual acuity in patients with diabetic macular edema.
Contrary to popular belief that PRP is associated with worsening of macular edema, we found that PRP + grid laser done for co-existent PDR and severe NPDR did not lead to worsening of treatment outcome. PRP done in severe NPDR / PDR patients associated with diabetic maculopathy has beneficial effects in stabilizing the visual acuity and reducing diabetic macular edema.
Laser photocoagulation done in severe NPDR patients approaching high risk characteristics PDR helps in stabilizing the visual acuity and prevents vision threatening complications.
Increasing duration of diabetes is associated with less favourable visual outcome after laser photocoagulation in diabetic patients.
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